Rathbones Group PLC Merck & Co., Inc. Transaction History

Rathbones Group PLC

  • $19 Billion
  • Q3 2024

A detailed history of Rathbones Group PLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Rathbones Group PLC holds 1,208,941 shares of MRK stock, worth $119 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
1,208,941
Previous 1,066,187 13.39%
Holding current value
$119 Million
Previous $132 Million 4.01%
% of portfolio
0.72%
Previous 0.74%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$111.15 - $128.97 $15.9 Million - $18.4 Million
142,754 Added 13.39%
1,208,941 $137 Million
Q2 2024

Aug 09, 2024
SELL
$123.8 - $132.96 $1.12 Million - $1.2 Million
-9,055 Reduced 0.84%
1,066,187 $132 Million
Q1 2024

May 14, 2024
BUY
$113.24 - $131.95 $5.21 Million - $6.07 Million
46,008 Added 4.47%
1,075,242 $142 Million
Q4 2023

Feb 13, 2024
BUY
$100.18 - $109.02 $7.73 Million - $8.41 Million
77,135 Added 8.1%
1,029,234 $112 Million
Q3 2023

Nov 13, 2023
BUY
$102.95 - $114.33 $10.1 Million - $11.3 Million
98,502 Added 11.54%
952,099 $98 Million
Q2 2023

Aug 04, 2023
BUY
$108.61 - $118.38 $13 Million - $14.2 Million
119,933 Added 16.35%
853,597 $98.5 Million
Q1 2023

May 12, 2023
BUY
$102.94 - $114.86 $21.9 Million - $24.4 Million
212,337 Added 40.73%
733,664 $78.1 Million
Q4 2022

Feb 14, 2023
BUY
$87.44 - $112.11 $15.1 Million - $19.4 Million
173,021 Added 49.67%
521,327 $57.8 Million
Q3 2022

Nov 03, 2022
BUY
$84.53 - $94.96 $23.7 Million - $26.6 Million
279,794 Added 408.39%
348,306 $30 Million
Q2 2022

Aug 12, 2022
SELL
$83.49 - $94.64 $416,615 - $472,253
-4,990 Reduced 6.79%
68,512 $6.25 Million
Q1 2022

May 11, 2022
SELL
$73.51 - $82.4 $20,435 - $22,907
-278 Reduced 0.38%
73,502 $6.03 Million
Q4 2021

Feb 10, 2022
BUY
$72.28 - $90.54 $59,992 - $75,148
830 Added 1.14%
73,780 $5.65 Million
Q3 2021

Nov 04, 2021
SELL
$71.68 - $78.83 $863,528 - $949,665
-12,047 Reduced 14.17%
72,950 $5.48 Million
Q2 2021

Jul 30, 2021
BUY
$70.31 - $77.77 $842,173 - $931,529
11,978 Added 16.4%
84,997 $6.61 Million
Q1 2021

May 14, 2021
SELL
$68.86 - $81.11 $31,882 - $37,553
-463 Reduced 0.63%
73,019 $5.63 Million
Q4 2020

Feb 11, 2021
BUY
$71.77 - $79.65 $76,793 - $85,225
1,070 Added 1.48%
73,482 $6.01 Million
Q3 2020

Nov 13, 2020
BUY
$73.18 - $82.95 $90,962 - $103,106
1,243 Added 1.75%
72,412 $6.01 Million
Q2 2020

Aug 07, 2020
BUY
$70.42 - $80.13 $1.08 Million - $1.23 Million
15,335 Added 27.47%
71,169 $5.5 Million
Q1 2020

May 04, 2020
SELL
$63.36 - $87.82 $218,592 - $302,979
-3,450 Reduced 5.82%
55,834 $4.3 Million
Q4 2019

Feb 11, 2020
BUY
$77.58 - $87.54 $111,327 - $125,619
1,435 Added 2.48%
59,284 $5.39 Million
Q3 2019

Nov 13, 2019
BUY
$76.08 - $82.93 $146,454 - $159,640
1,925 Added 3.44%
57,849 $4.87 Million
Q2 2019

Aug 12, 2019
SELL
$69.84 - $81.59 $1,815 - $2,121
-26 Reduced 0.05%
55,924 $4.69 Million
Q1 2019

May 09, 2019
SELL
$69.58 - $79.36 $14,124 - $16,110
-203 Reduced 0.36%
55,950 $4.65 Million
Q4 2018

Feb 12, 2019
BUY
$65.24 - $75.71 $67,066 - $77,829
1,028 Added 1.86%
56,153 $4.29 Million
Q3 2018

Oct 12, 2018
BUY
$57.69 - $67.84 $8,076 - $9,497
140 Added 0.25%
55,125 $3.91 Million
Q2 2018

Jul 16, 2018
SELL
$50.83 - $59.72 $18,298 - $21,499
-360 Reduced 0.65%
54,985 $3.34 Million
Q1 2018

Apr 06, 2018
SELL
$50.96 - $59.23 $47,749 - $55,498
-937 Reduced 1.66%
55,345 $3.02 Million
Q4 2017

Jan 24, 2018
BUY
$51.62 - $61.64 $21,215 - $25,334
411 Added 0.74%
56,282 $3.17 Million
Q3 2017

Oct 24, 2017
BUY
$58.67 - $63.13 $3.28 Million - $3.53 Million
55,871
55,871 $3.58 Million

Others Institutions Holding MRK

# of Institutions
3,827
Shares Held
1.87B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Rathbones Group PLC Portfolio

Follow Rathbones Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email